VKTX
Conviction 71HealthcareScan · Thu, Sep 24, 2026Viking Therapeutics, Inc. (VKTX) closed at $36.75 (-11.76%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 57, RS Rating 85, -12.8% from its 52-week high, +3.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior NotesPR Newswire · Thu, Sep 24, 2026
- Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior NotesPR Newswire · Wed, Sep 23, 2026
- Viking Therapeutics, Inc.: Follow-on stock offering (dilution)SEC EDGAR · Wed, Sep 23, 2026
- Viking Therapeutics, Inc.: Material event (8-K)SEC EDGAR · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in VKTX
Insider activity
SEC Form 4 transactions in VKTX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kelly-Gemmell Dorothy Elizabeth Director · Common Stock, par value $0.00001 per share · 2026-08-01 | Grant | 6.33K | — | 2026-08-01 | 2026-08-07 |
Kelly-Gemmell Dorothy Elizabeth Director · Stock Option (Right to Buy) · 2026-08-01 | Grant | 40.8K | — | 2026-08-01 | 2026-08-07 |
Chen Hubert C Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-01 | Grant | 190K | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in VKTX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.